ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹16,199 Cr (+11.9% YoY) and net profit of ₹1,995 Cr (-36.2% YoY) for Q2 FY27.
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹15,300 Cr (+10.5% YoY) and net profit of ₹2,895 Cr (+27.0% YoY) for Q1 FY27.
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹14,612 Cr (+12.8% YoY) and net profit of ₹2,714 Cr (+26.2% YoY) for Q4 FY26.
Sun Pharma reported FY26 consolidated revenue of ₹58,220.11 Crore with a 11.9% growth. The board recommended a final dividend of ₹5 per share for the year.
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹14,612 Cr (+12.8% YoY) and net profit of ₹2,724 Cr (+26.1% YoY) for Q4 FY26.
Sun Pharma approved audited FY26 results and recommended a final dividend of Rs. 5 per share. Consolidated sales reached ₹58,462.04 Crore, marking 11.9% year-on-year growth.